🇺🇸 FDA
Patent

US 12364668

Treatment of opioid use disorder, opioid withdrawal symptoms, and chronic pain

granted A61KA61K2236/30A61K31/05

Quick answer

US patent 12364668 (Treatment of opioid use disorder, opioid withdrawal symptoms, and chronic pain) held by The Regents of the University of California expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2236/30, A61K31/05, A61K31/4375, A61K31/485